000 01560 a2200409 4500
005 20250517170223.0
264 0 _c20180108
008 201801s 0 0 eng d
022 _a1879-0887
024 7 _a10.1016/j.radonc.2017.07.024
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSharma, Ashish
245 0 0 _aThe novel microtubule targeting agent BAL101553 in combination with radiotherapy in treatment-refractory tumor models.
_h[electronic resource]
260 _bRadiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
_c09 2017
300 _a433-438 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAnimals
650 0 4 _aBenzimidazoles
_xtherapeutic use
650 0 4 _aCell Line, Tumor
650 0 4 _aChemoradiotherapy
650 0 4 _aHumans
650 0 4 _aMice
650 0 4 _aMicrotubules
_xdrug effects
650 0 4 _aNeoplasms, Experimental
_xpathology
650 0 4 _aOxadiazoles
_xtherapeutic use
650 0 4 _aXenograft Model Antitumor Assays
700 1 _aBroggini-Tenzer, Angela
700 1 _aVuong, Van
700 1 _aMessikommer, Alessandra
700 1 _aNytko, Katarzyna J
700 1 _aGuckenberger, Matthias
700 1 _aBachmann, Felix
700 1 _aLane, Heidi A
700 1 _aPruschy, Martin
773 0 _tRadiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
_gvol. 124
_gno. 3
_gp. 433-438
856 4 0 _uhttps://doi.org/10.1016/j.radonc.2017.07.024
_zAvailable from publisher's website
999 _c27455274
_d27455274